Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

The Gut Microbiota Is Associated with Clearance of Clostridium difficile Infection Independent of Adaptive Immunity.

Leslie JL, Vendrov KC, Jenior ML, Young VB.

mSphere. 2019 Jan 30;4(1). pii: e00698-18. doi: 10.1128/mSphereDirect.00698-18.

2.

The Microbiome and Endothelial Function.

Leslie JL, Annex BH.

Circ Res. 2018 Oct 12;123(9):1015-1016. doi: 10.1161/CIRCRESAHA.118.313813. No abstract available.

PMID:
30355167
3.

Clostridium difficile Alters the Structure and Metabolism of Distinct Cecal Microbiomes during Initial Infection To Promote Sustained Colonization.

Jenior ML, Leslie JL, Young VB, Schloss PD.

mSphere. 2018 Jun 27;3(3). pii: e00261-18. doi: 10.1128/mSphere.00261-18. Print 2018 Jun 27.

4.

Clostridium difficile Colonizes Alternative Nutrient Niches during Infection across Distinct Murine Gut Microbiomes.

Jenior ML, Leslie JL, Young VB, Schloss PD.

mSystems. 2017 Jul 25;2(4). pii: e00063-17. doi: 10.1128/mSystems.00063-17. eCollection 2017 Jul-Aug.

5.

Resilience As a Life Practice: Lessons from Mother Seton.

Leslie JL, Wray JN, Lonneman W.

J Christ Nurs. 2017 Jan/Mar;34(1):29-33.

PMID:
27956725
6.

Expanding the Moral Imagination: The Social Class Dinner.

Leslie JL.

J Nurs Educ. 2016 Apr;55(4):240. doi: 10.3928/01484834-20160316-12. No abstract available.

PMID:
27023897
7.

Improving Class Discussion for an Evidence-Based Practice Course.

Leslie JL.

J Nurs Educ. 2016 Mar;55(3):182. doi: 10.3928/01484834-20160216-12. No abstract available.

PMID:
26926223
8.

Promoting Trust in the Registered Nurse-Patient Relationship.

Leslie JL, Lonneman W.

Home Healthc Now. 2016 Jan;34(1):38-42. doi: 10.1097/NHH.0000000000000322. Review.

PMID:
26645843
9.

A whole new ball game: Stem cell-derived epithelia in the study of host-microbe interactions.

Leslie JL, Young VB.

Anaerobe. 2016 Feb;37:25-8. doi: 10.1016/j.anaerobe.2015.10.016. Epub 2015 Nov 5. Review.

10.

Overdiagnosis of Clostridium difficile Infection in the Molecular Test Era.

Polage CR, Gyorke CE, Kennedy MA, Leslie JL, Chin DL, Wang S, Nguyen HH, Huang B, Tang YW, Lee LW, Kim K, Taylor S, Romano PS, Panacek EA, Goodell PB, Solnick JV, Cohen SH.

JAMA Intern Med. 2015 Nov;175(11):1792-801. doi: 10.1001/jamainternmed.2015.4114.

11.

Why should you attend a conference this year?

Leslie JL.

Nursing. 2015 Jan;45(1):48-51. doi: 10.1097/01.NURSE.0000458921.72726.17. No abstract available.

PMID:
25532985
12.

The rest of the story: the microbiome and gastrointestinal infections.

Leslie JL, Young VB.

Curr Opin Microbiol. 2015 Feb;23:121-5. doi: 10.1016/j.mib.2014.11.010. Epub 2014 Dec 2. Review.

13.

Persistence and toxin production by Clostridium difficile within human intestinal organoids result in disruption of epithelial paracellular barrier function.

Leslie JL, Huang S, Opp JS, Nagy MS, Kobayashi M, Young VB, Spence JR.

Infect Immun. 2015 Jan;83(1):138-45. doi: 10.1128/IAI.02561-14. Epub 2014 Oct 13.

14.

Clostridium difficile-induced colitis in mice is independent of leukotrienes.

Trindade BC, Theriot CM, Leslie JL, Carlson PE Jr, Bergin IL, Peters-Golden M, Young VB, Aronoff DM.

Anaerobe. 2014 Dec;30:90-8. doi: 10.1016/j.anaerobe.2014.09.006. Epub 2014 Sep 16.

15.

Evaluation of Clostridium difficile fecal load and limit of detection during a prospective comparison of two molecular tests, the illumigene C. difficile and Xpert C. difficile/Epi tests.

Gyorke CE, Wang S, Leslie JL, Cohen SH, Solnick JV, Polage CR.

J Clin Microbiol. 2013 Jan;51(1):278-80. doi: 10.1128/JCM.02120-12. Epub 2012 Oct 10.

16.

Outcomes in patients tested for Clostridium difficile toxins.

Polage CR, Chin DL, Leslie JL, Tang J, Cohen SH, Solnick JV.

Diagn Microbiol Infect Dis. 2012 Dec;74(4):369-73. doi: 10.1016/j.diagmicrobio.2012.08.019. Epub 2012 Sep 23.

17.

Role of fecal Clostridium difficile load in discrepancies between toxin tests and PCR: is quantitation the next step in C. difficile testing?

Leslie JL, Cohen SH, Solnick JV, Polage CR.

Eur J Clin Microbiol Infect Dis. 2012 Dec;31(12):3295-9. doi: 10.1007/s10096-012-1695-6. Epub 2012 Jul 20. Erratum in: Eur J Clin Microbiol Infect Dis. 2012 Dec;31(12):3301.

18.
20.
21.

Identification of formulation and manufacturing variables that influence in vitro dissolution and in vivo bioavailability of propranolol hydrochloride tablets.

Eddington ND, Ashraf M, Augsburger LL, Leslie JL, Fossler MJ, Lesko LJ, Shah VP, Rekhi GS.

Pharm Dev Technol. 1998 Nov;3(4):535-47.

PMID:
9834957

Supplemental Content

Loading ...
Support Center